RNase H hydrolysis of the 5' terminus of the avian sarcoma virus genome during reverse transcription.

Effect of viral RNase H on the avian sarcoma viral genome during early transcription in vitro.

Nucleotide sequence at the 5' terminus of the avian sarcoma virus genome.

Two avian sarcoma virus mutants with defects in the DNA polymerase-RNase H complex.

Discrimination of DNA polymerase and RNase H activities in reverse transcriptase of avian myeloblastosis virus.

Abortive reverse transcription by mutants of Moloney murine leukemia virus deficient in the reverse transcriptase-associated RNase H function.

Extensive in vitro transcription of rous sarcoma virus RNA by avian myeloblastosis virus DNA polymerase and concurrent activation of the associated RNase H.

Terminally repeated sequences in the avian sarcoma virus RNA genome.

Further characterization of the Friend murine leukemia virus reverse transcriptase-RNase H complex.

Inhibition of foamy virus reverse transcriptase by human immunodeficiency virus type 1 RNase H inhibitors.

Host induced alteration of avian sarcoma virus B-77 genome.

Reverse transcriptase of RNA tumor viruses. V. In vitro proteolysis of reverse transcriptase from avian myeloblastosis virus and isolation of a polypeptide manifesting only RNase H activity.

Evidence for circularization of the avian oncornavirus RNA genome during proviral DNA synthesis from studies of reverse transcription in vitro.

In vitro synthesis of infectious transforming DNA by the avian sarcoma virus reverse transcriptase.

Physical map of the Kirsten sarcoma virus genome as determined by fingerprinting RNase T1-resistant oligonucleotides.

Evidence for the identity of shared 5'-terminal sequences between genome RNA and subgenomic mRNA's of B77 avian sarcoma virus.

Rous sarcoma virus genome is terminally redundant: the 5' sequence.

Cellular information in the genome of recovered avian sarcoma virus directs the synthesis of transforming protein.

Avian retrovirus RNA-directed DNA synthesis: transcription at the 5' terminus of the viral genome and the functional role for the viral terminal redundancy.

New procedure for the direct analysis of in vitro reverse transcription of Rous sarcoma virus RNA.

In vitro transcription of 70S RNA by the RNA-directed DNA polymerase of Rouse sarcoma virus: lack of influence of RNase H.

Illimaquinone, a selective inhibitor of the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase.

Reverse transcriptase-associated RNase H. Part IV. Pyrophosphate does not inhibit RNase H activity of AMV DNA polymerase.

Effect of 5-methylcytidine on virus production in avian sarcoma virus-infected chicken embryo cells.

Immunogenicity of the envelope glycoprotein of avian sarcoma virus.

Suggest Documents

Effect of viral RNase H on the avian sarcoma viral genome during early transcription in vitro.

Nucleotide sequence at the 5' terminus of the avian sarcoma virus genome.

Two avian sarcoma virus mutants with defects in the DNA polymerase-RNase H complex.

Discrimination of DNA polymerase and RNase H activities in reverse transcriptase of avian myeloblastosis virus.

Abortive reverse transcription by mutants of Moloney murine leukemia virus deficient in the reverse transcriptase-associated RNase H function.

Extensive in vitro transcription of rous sarcoma virus RNA by avian myeloblastosis virus DNA polymerase and concurrent activation of the associated RNase H.

Terminally repeated sequences in the avian sarcoma virus RNA genome.

Further characterization of the Friend murine leukemia virus reverse transcriptase-RNase H complex.

Inhibition of foamy virus reverse transcriptase by human immunodeficiency virus type 1 RNase H inhibitors.

Host induced alteration of avian sarcoma virus B-77 genome.

Reverse transcriptase of RNA tumor viruses. V. In vitro proteolysis of reverse transcriptase from avian myeloblastosis virus and isolation of a polypeptide manifesting only RNase H activity.

Evidence for circularization of the avian oncornavirus RNA genome during proviral DNA synthesis from studies of reverse transcription in vitro.

In vitro synthesis of infectious transforming DNA by the avian sarcoma virus reverse transcriptase.

Physical map of the Kirsten sarcoma virus genome as determined by fingerprinting RNase T1-resistant oligonucleotides.

Evidence for the identity of shared 5'-terminal sequences between genome RNA and subgenomic mRNA's of B77 avian sarcoma virus.

Rous sarcoma virus genome is terminally redundant: the 5' sequence.

Cellular information in the genome of recovered avian sarcoma virus directs the synthesis of transforming protein.

Avian retrovirus RNA-directed DNA synthesis: transcription at the 5' terminus of the viral genome and the functional role for the viral terminal redundancy.

New procedure for the direct analysis of in vitro reverse transcription of Rous sarcoma virus RNA.

In vitro transcription of 70S RNA by the RNA-directed DNA polymerase of Rouse sarcoma virus: lack of influence of RNase H.

Illimaquinone, a selective inhibitor of the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase.

Reverse transcriptase-associated RNase H. Part IV. Pyrophosphate does not inhibit RNase H activity of AMV DNA polymerase.

Effect of 5-methylcytidine on virus production in avian sarcoma virus-infected chicken embryo cells.

Immunogenicity of the envelope glycoprotein of avian sarcoma virus.

RNase H hydrolysis of the 5' terminus of the avian sarcoma virus genome during reverse transcription.

Recommend Documents

Follow Us